Atlas Trials

Renal Function Improvement in HBsAg Positive Kidney Transplantation Patients Under Telbivudine Treatment.

Clinical trial NCT02894554 · TERMINATED

Trial details

NCT number
NCT02894554
Sponsor
National Taiwan University Hospital
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
HBsAg-positive Renal Allograft Recipients
Start date
2014-07-01
Primary completion
2014-10-01
Enrollment
19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.